While COVID-19 has presented extraordinary challenges globally, no one has felt it more acutely than those on the frontline, our incredibly brave healthcare workers. El Camino Health has been at the forefront of this crisis in an effort to stay ahead of the curve and prepare not only its own hospitals, but others in the area to best support Bay Area patients.
When he is not helping a patient, mentoring entrepreneurs at Stanford Biodesign, supporting the Fogarty Institute as a board member or assessing how to develop a new medical device, Fred St Goar, MD, is looking for ways to help improve the global health system. Through a lifetime of fascinating medical experiences, he is well-equipped to wear all those hats equally well.
It was a full house at the Fogarty Institute’s latest educational seminar titled “Fundraising – Art or Science?” highlighting the need and interest in this important topic. After all, it drives the future of all startups, but is particularly pertinent to early-stage companies immersed in finding appropriate funding.*
Attendees were also drawn to the breadth of experience of the speakers,
It has been an action-packed 12 months for EnSpectra Health, a Fogarty Institute company that is leading a digital transformation in skin cancer pathology. While 2019 brought a number of notable developments, most recently EnSpectra received a $2 million grant that will expedite the introduction of its groundbreaking skin cancer identification technology.
As a society, we have found our lives upended as we adjust to new routines, including, for many of us, working from home while juggling caregiving and schooling. Add to that social distancing; although vital, it can contribute to people feeling disconnected while we are also emotionally drained, stressed and fearful. It’s easy to see that managing mental health is more important than ever.
When healthcare innovation drives you, the possibilities are endless. Like many successful healthtech entrepreneurs, Gordon Saul has worn many hats throughout his career, experiencing the industry from many different angles. Today, he is an integral part of an incredibly talented team as executive director at Stanford Byers Center for Biodesign, an organization that we are honored to have been partnering and collaborating with for many years.
“My advice for you is to use your very best judgment in making life’s major decisions; follow your passion and your heart as you embark on life’s wonderful journey that lies ahead of you. Pursue your dreams until the day you die. Don’t take yourself too seriously and laugh every single day. Live your life ‘The Carolina Way,’ with hard work,
“We were given a gift to be able to solve a big problem, and though the road to getting a device to market is often a bumpy one, we have never lost our resolve to keep moving forward.”
That focus from Madorra, a Fogarty Institute graduate aiming to improve the quality of life for breast cancer survivors and post-menopausal women,
The growing size and influence of the much-anticipated 38th Annual J.P. Morgan Healthcare Conference continues to drive high attendance and concurrent events. This year, the Fogarty Institute played a larger role by hosting its first Innovator’s reception in partnership with Stanford Biodesign, The MedTech Strategist, RCT and the MedTech Innovator.
The reception was a success,
The Fogarty Institute continues to build its bench strength with the recent hire of seasoned medtech leader Marga Ortigas-Wedekind as chief commercial strategy officer. With 30 years of experience in medical and health technology companies at a variety of stages of development, her expertise will make her an asset to the entire team, most notably to our entrepreneurs,